Related Experiment Video

Updated: May 18, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Curtailing overexpression of E2F3 in breast cancer using siRNA (E2F3)-based gene silencing

Karuppaiya Vimala1, Shenbagamoorthy Sundarraj, Mohanan V Sujitha

  • 1Proteomics and Molecular Cell Physiology Laboratory, Department of Zoology, School of Life Sciences, Bharathiar University, Coimbatore, TN 641046, India.

Archives of Medical Research
|September 11, 2012
PubMed
Abstract

Insights

E2F3 transcription factor is overexpressed in breast cancer cell lines. Small interfering RNA (siRNA) targeting E2F3 effectively silenced its expression, demonstrating its potential as a therapeutic strategy for breast cancer.

Area of Science:

  • Molecular biology
  • Cancer research
  • Genetics

Background:

  • The E2F3 transcription factor is implicated in cell cycle control and has been linked to bladder and prostate cancer development.
  • Overexpression of nuclear E2F3 is associated with increased cancer risk.

Purpose of the Study:

  • To investigate the extent of E2F3 overexpression in breast cancer.
  • To evaluate the efficacy of small interfering RNA (siRNA) targeting E2F3 in breast cancer cell lines.

Main Methods:

  • Quantitative real-time PCR was used to analyze E2F3 expression levels in breast cancer cell lines.
  • Western blotting was performed to measure E2F3a and E2F3b protein levels.

Main Results:

  • E2F3 was found to be overexpressed in 11 out of 11 tested breast cancer cell lines.
  • siRNA specifically designed against E2F3 successfully inhibited E2F3 expression in these cell lines.
  • The study confirmed the efficiency of siRNA-mediated E2F3 gene silencing.

Conclusions:

  • E2F3 represents a novel diagnostic and potential therapeutic target for breast cancer.
  • siRNA targeting E2F3 demonstrates efficacy in silencing E2F3 overexpression and combating breast cancer.
  • E2F3 and its targeted therapies offer a promising alternative for breast cancer diagnosis and treatment.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

MISSION esiRNA for RNAi Screening in Mammalian Cells15:31

MISSION esiRNA for RNAi Screening in Mammalian Cells

Published on: May 12, 2010

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...